104 related articles for article (PubMed ID: 2342391)
1. [Different behavior of bone turnover markers in endocrine (extrinsic) and structural (intrinsic) osteopathies].
Napal J; Amado JA; Riancho JA; Freijanes J; Pesquera C; González-Macías J
Med Clin (Barc); 1990 Mar; 94(8):294-8. PubMed ID: 2342391
[TBL] [Abstract][Full Text] [Related]
2. [Bone turnover markers in tumor pathology with bone involvement].
Napal Lecumberri J; Amado Señarís JA; Pesquera C; Riancho JA; González Macías J
Med Clin (Barc); 1990 Apr; 94(13):487-9. PubMed ID: 2355762
[TBL] [Abstract][Full Text] [Related]
3. Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism.
Stĕpán JJ; Mikulecký M; Bek V; Broulík P; Pacovský V
Neoplasma; 1989; 36(4):495-501. PubMed ID: 2770935
[TBL] [Abstract][Full Text] [Related]
4. Biochemical markers of bone turnover.
Rosalki SB
Int J Clin Pract; 1998 Jun; 52(4):255-6. PubMed ID: 9744151
[TBL] [Abstract][Full Text] [Related]
5. Procollagen type I carboxy-terminal propeptide as a marker of osteoblastic bone metastases.
Francini G; Gonnelli S; Petrioli R; Bruni S; Marsili S; Aquino A; Camporeale A
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):125-9. PubMed ID: 8467247
[TBL] [Abstract][Full Text] [Related]
6. Biochemical markers of bone turnover: an update.
van Daele PL; Birkenhäger JC; Pols HA
Neth J Med; 1994 Feb; 44(2):65-72. PubMed ID: 8208326
[TBL] [Abstract][Full Text] [Related]
7. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.
Charles P; Poser JW; Mosekilde L; Jensen FT
J Clin Invest; 1985 Dec; 76(6):2254-8. PubMed ID: 3878367
[TBL] [Abstract][Full Text] [Related]
8. [Osteocalcin, a marker in diseases with elevated bone metabolism].
Stracke H; Schatz C; Pralle H; Ullmann J; Schatz H
Dtsch Med Wochenschr; 1985 Sep; 110(38):1442-6. PubMed ID: 3875469
[TBL] [Abstract][Full Text] [Related]
9. [Changes in phospho-calcium metabolic factors in function of the rate of bone turnover. Epidemiologic study of osteoporosis (part 2)].
Maini M; Brignoli E; Felicetti G; Bozzi M
Minerva Med; 1996 Dec; 87(12):565-76. PubMed ID: 9064593
[TBL] [Abstract][Full Text] [Related]
10. Osteocalcin and bone remodelling in Paget's disease of bone, primary hyperparathyroidism, hypercalcaemia of malignancy and involutional osteoporosis.
Torres R; de la Piedra C; Rapado A
Scand J Clin Lab Invest; 1989 May; 49(3):279-85. PubMed ID: 2787049
[TBL] [Abstract][Full Text] [Related]
11. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.
Kaddam IM; Iqbal SJ; Holland S; Wong M; Manning D
Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():327-30. PubMed ID: 7979096
[TBL] [Abstract][Full Text] [Related]
12. [Use of biochemical markers of bone turnover in Paget's disease of bone].
Vignot E; Meunier PJ
Ann Biol Clin (Paris); 2001; 59(3):309-11. PubMed ID: 11397680
[No Abstract] [Full Text] [Related]
13. Influence of sex and age on biochemical bone metabolism parameters.
Resch H; Pietschmann P; Kudlacek S; Woloszczuk W; Krexner E; Bernecker P; Willvonseder R
Miner Electrolyte Metab; 1994; 20(3):117-21. PubMed ID: 7815999
[TBL] [Abstract][Full Text] [Related]
14. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients.
Bozkaya G; Nart A; Uslu A; Onman T; Aykas A; Doğan M; Karaca B
Transplant Proc; 2008; 40(1):151-5. PubMed ID: 18261573
[TBL] [Abstract][Full Text] [Related]
15. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of the measurement of bone remodelling markers in primary hyperparathyroidism.
Minisola S; Scarnecchia L; Carnevale V; Bigi F; Romagnoli E; Pacitti MT; Rosso R; Mazzuoli GF
J Endocrinol Invest; 1989 Sep; 12(8):537-42. PubMed ID: 2592739
[TBL] [Abstract][Full Text] [Related]
17. [Urinary hydroxyproline correlated with quantitative bone histological data. Attempted physiopathological interpretation].
Lejeune E; Meunier P; Ruitton P; Orgiazzi J
Rev Rhum Mal Osteoartic; 1972 Feb; 39(2):107-13. PubMed ID: 4343436
[No Abstract] [Full Text] [Related]
18. Hypophosphatemic osteomalacia: a report of five cases and evaluation of bone markers.
Ros I; Alvarez L; Guañabens N; Peris P; Monegal A; Vázquez I; Cerdá D; Ballesta AM; Muñoz-Gómez J
J Bone Miner Metab; 2005; 23(3):266-9. PubMed ID: 15838631
[TBL] [Abstract][Full Text] [Related]
19. Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism.
Stĕpán JJ; Presl J; Broulík P; Pacovský V
J Clin Endocrinol Metab; 1987 May; 64(5):1079-82. PubMed ID: 3031119
[TBL] [Abstract][Full Text] [Related]
20. Calcitropic hormonal status in north Indian patients with end-stage renal disease.
Singh AK; Avula S; Kher V; Rao DS; Mithal A
Natl Med J India; 1999; 12(5):202-7. PubMed ID: 10612998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
